Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-23-006374
Filing Date
2023-09-12
Accepted
2023-09-11 21:56:25
Documents
18

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 2 pharmacyte_s3a2.htm   iXBRL S-3/A 224273
2 CONSENT OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND POPEO P.C. pharmacyte_ex0501.htm EX-5.1 14220
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM pharmacyte_ex2301.htm EX-23.1 2954
4 EXHIBIT 107 pharmacyte_ex107.htm EX-FILING FEES 10883
5 GRAPHIC image_001.gif GRAPHIC 3965
9 GRAPHIC image_002.jpg GRAPHIC 2815
  Complete submission text file 0001683168-23-006374.txt   469462

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pmcb-20230911.xsd EX-101.SCH 3021
7 XBRL LABEL FILE pmcb-20230911_lab.xml EX-101.LAB 34767
8 XBRL PRESENTATION FILE pmcb-20230911_pre.xml EX-101.PRE 22721
11 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_s3a2_htm.xml XML 2778
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: S-3/A | Act: 33 | File No.: 333-272569 | Film No.: 231248918
SIC: 2836 Biological Products, (No Diagnostic Substances)